HIGH POINT, N.C.–(BUSINESS WIRE)–Nov. 19, 2018– vTv Therapeutics Inc. (Nasdaq: VTVT) today announced that company management will present a corporate overview at the Piper Jaffray 30th Annual Healthcare Conference on Tuesday, Nov. 27, 2018 at 2:10 p.m. ET in New York City.
A live webcast of the presentation can be accessed here and will be archived for 30
LIVONIA, Mich., Nov. 6, 2018: Valassis Digital, a leading digital marketing intelligence company, announced today its alignment with Allant Group, a nationally recognized data-driven analytics and marketing firm. This partnership provides marketers with an advanced solution connecting robust customer understanding with precise marketing activation.
The combined
NEW YORK, Nov. 01, 2018 (GLOBE NEWSWIRE) — SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it has entered into an agreement to sell its medical countermeasures priority review voucher (PRV) for a lump sum payment of $80 million. SIGA was
SOUTH BEND, Ind., and ROCK ISLAND, Ill., Thursday, Nov. 1, 2018 – Global mobility solutions provider, AM General, today announced that it has made an investment in Mandus Group, an innovator of artillery solutions based on soft recoil technology, headquartered in Rock Island, Illinois.
HIGH POINT, N.C.–(BUSINESS WIRE)–Oct. 29, 2018– vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered treatments for Alzheimer’s disease (AD) and diabetes, today announced that The NASDAQ Stock Market LLC (“Nasdaq”) has approved the Company’s application to list its Class
LIVONIA, Mich., Oct. 24, 2018: Valassis, a leader in activating consumers through intelligent media delivery, announced today that Market Magazine will join Clipper, the Valassis-owned magazine focused on local businesses, continuing the trajectory of growing its presence in the hyperlocal marketing industry. Market Magazine operates
HIGH POINT, N.C.–(BUSINESS WIRE)–Oct. 24, 2018– vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered treatments for Alzheimer’s disease (AD) and diabetes, today announced that a subgroup analysis from the azeliragon Phase 3 STEADFAST trial was presented at
EAGAN, Minn.–(BUSINESS WIRE)–Scantron Corporation, a leading, global provider of assessment solutions, technology solutions and scanners and forms, is changing the way people think about the testing icon by updating its brand and positioning. For more than 40 years, Scantron has continued to supply the
SOUTH BEND, Ind., October 22, 2018 – Global vehicle solutions provider, AM General, has received an order to provide 740 new M1152A1 High Mobility Multipurpose Wheeled Vehicles (HMMWV) to the U.S. Army National Guard as a part of their modernization initiatives valued at $89
HIGH POINT, N.C.–(BUSINESS WIRE)–Oct. 16, 2018– vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered treatments for Alzheimer’s disease and diabetes, today announced that it will deliver an oral presentation and present a poster at the 11th Clinical Trials
Gallery
Gallery
Gallery
Gallery
Gallery